What is HC Wainwright’s Estimate for PTGX FY2026 Earnings?

Дата публикации: 10-08-2026 05:28:54

Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Equities research analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for Protagonist Therapeutics in a research note issued to investors on Thursday, August 6th. HC Wainwright analyst D. Tsao now anticipates that the company will earn $4.00 per share for the year, down […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	HC Wainwright Has Optimistic Outlook of TNYA FY2026 Earnings	0	11.9	10-08-2026
2	Q3 EPS Estimates for CG Oncology Lowered by HC Wainwright	0	11.48	10-08-2026
3	Research Analysts Offer Predictions for CMPX Q3 Earnings	0	11.48	10-08-2026
4	HC Wainwright Issues Pessimistic Estimate for ARWR Earnings	0	13.33	10-08-2026
5	HC Wainwright Has Positive Forecast for ARQT Q3 Earnings	0	11.13	10-08-2026
6	HC Wainwright Issues Optimistic Estimate for CNTX Earnings	0	12.95	10-08-2026
7	FY2026 EPS Estimates for Fuel Tech Decreased by Analyst	0	12.27	10-08-2026
8	FY2026 EPS Estimates for Galiano Gold Lowered by Analyst	0	12.64	10-08-2026
9	Brokers Offer Predictions for Centrus Energy FY2026 Earnings	0	14.22	10-08-2026
10	Analysts Issue Forecasts for Energy Fuels FY2026 Earnings	0	13.04	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.4. Источник: www.americanbankingnews.com.